Ellison S, Pardridge W M
Department of Medicine, UCLA School of Medicine 90024.
Neurochem Res. 1990 Aug;15(8):769-72. doi: 10.1007/BF00968552.
The possibility that red cell-sequestered amino acids such as phenylalanine are available for transport through the brain capillary wall, i.e., the blood-brain barrier (BBB), in vivo was investigated in the present studies with the carotid artery injection technique. Control studies included the examination of the availability of red cell-sequestered solutes such as phenylalanine or D-glucose to liver cells in vivo using a portal vein injection technique. The results show that red cell-sequestered phenylalanine is not available for transport through the BBB or into rat liver in vivo, but human red cell-sequestered D-glucose is available for uptake by liver following portal injection. Therefore, given favorable kinetics it is possible for red cell-sequestered solute to be available for uptake by tissues. However, in the case of neutral amino acids such as phenylalanine, red cell-sequestered amino acid is not available for transport through the BBB in vivo.
在本研究中,采用颈动脉注射技术,对体内红细胞隔离的氨基酸(如苯丙氨酸)是否可通过脑毛细血管壁(即血脑屏障,BBB)进行转运进行了研究。对照研究包括采用门静脉注射技术,检测体内红细胞隔离的溶质(如苯丙氨酸或D-葡萄糖)对肝细胞的可用性。结果表明,红细胞隔离的苯丙氨酸在体内不能通过血脑屏障或转运至大鼠肝脏,但人红细胞隔离的D-葡萄糖在门静脉注射后可被肝脏摄取。因此,在有利的动力学条件下,红细胞隔离的溶质有可能被组织摄取。然而,对于苯丙氨酸等中性氨基酸,红细胞隔离的氨基酸在体内不能通过血脑屏障进行转运。